Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Feb 2011

Plon Sharon E, Cooper H Paul, Parks Bethany, Dhar Shweta U, Kelly P Adam, Weinberg Armin D, Staggs Stephanie, Wang Tao, Hilsenbeck Susan

Abstract excerpt

PURPOSE: Sequence-based cancer susceptibility testing results are described as negative, deleterious mutation or variant of uncertain significance. We studied the impact of different types of test results on clinical decision making. METHODS: Practicing physicians from five specialties in Texas completed an online case-based survey (n = 225). Respondents were asked to make genetic testing and management...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Costs and Cost Analysis
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Health Care Surveys

Share to Physicians

Share to Risk Management

Source

Open in PubMed Open full text

Identifiers

PMID: 21224735
DOI: 10.1097/GIM.0b013e318207f564
PMCID: PMC3096073

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.PMID 21224735Read ↗

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast CancerSemantic proximity Read ↗

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.Semantic proximity Read ↗

Physician interpretation of variants of uncertain significance.Semantic proximity Read ↗

Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.Semantic proximity Read ↗

Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Semantic proximity Read ↗

Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.Semantic proximity Read ↗

BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.Semantic proximity Read ↗

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer RiskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.